Back to search
Scientific Name: Linagliptin
Brand Name: Glyxambi, Jentadueto, Tradjenta, Trajenta, Trijardy
Company Owner: Not Available
Mechanism Of Action Linagliptin is a competitive, reversible DPP-4 inhibitor. Inhibition of this enzyme slows the breakdown of GLP-1 and glucose-dependant insulinotropic polypeptide (GIP)
Description of the Drug: Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used to manage hyperglycemia in patients with type 2 diabetes mellitus.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from